Since July 2024, faricimab has also been approved in Europe for the treatment of visual impairment due to macular oedema ...

Diabetic macular edema remains an important cause of vision loss among patients with diabetes mellitus. Improved control of blood pressure and blood sugar, as well as photocoagulation, are ...

any of which can include the involvement of diabetic macular edema. With appropriate treatment, clinical trials have shown that severe vision loss can be prevented in most patients. [194] The ...

Approximately 90% of aflibercept 8 mg patients were extended to every 8-week dosing and maintained their interval through 36 weeks ...